FRETS-VWF73

Documents

Asp-Arg-Glu-A₂pr(Nma)-Ala-Pro-Asn-Leu-Val-Tyr-Met-Val-Thr-Gly-A₂pr(Dnp)-Pro-Ala-Ser-Asp-Glu-Ile-Lys-Arg-Leu-Pro-Gly-Asp-Ile-Gln-Val-Val-Pro-Ile-Gly-Val-Gly-Pro-Asn-Ala-Asn-Val-Gln-Glu-Leu-Glu-Arg-Ile-Gly-Trp-Pro-Asn-Ala-Pro-Ile-Leu-Ile-Gln-Asp-Phe-Glu-Thr-Leu-Pro-Arg-Glu-Ala-Pro-Asp-Leu-Val-Leu-Gln-Arg A₂pr(Nma): N^β-[2-(Methylamino)benzoyl]-2,3-diaminopropionic acid A₂pr(Dnp): N^β-(2,4-Dinitrophenyl)-2,3-diaminopropionic acid
: (Trifluoroacetate Form)
: (M.W. 8314.3) C₃₇₀H₅₈₃N₁₀₃O₁₁₃S
: Fluorescence-Quenching Substrate for ADAMTS-13

Package	Price(Yen)	Availability
Vial 0.1 mg	32,000	contact us
Bulk Request

Solubility: DMSO (0.4 mM)

K. Kokame, M. Matsumoto, Y. Fujimura, and T. Miyata, Blood, 103, 607 (2004). (VWF73 Sequence)
K. Kokame, Y. Nobe, Y. Kokubo, A. Okayama, and T. Miyata, Br. J. Haematol., 129, 93 (2005). (FRETS-VWF73)
E. Groot, J.J.J. Hulstein, C.N. Rison, P.G. De Groot, and R. Fijnheer, J. Thromb. Haemost., 4, 698 (2006). (ADAMTS-13 Assay)

Data Sheet